Skip to main content

Table 2 Individual study results included in the network meta-analysis

From: Comparison of the effectiveness of polyethylene glycol with and without electrolytes in constipation: a systematic review and network meta-analysis

Study

Assessment timea

Stools per week (number of patients)

Low risk of bias

PEG + E

PEG

Placebo

Lactulose

Serotonin agonist

Bulk forming

Awad RA 2010 [14]

30 days

 

4.1 (N = 23)

4.0 (N = 24)

   

Yes

Cleveland MV 2001 [19]

14 days

 

7.0 (N = 23)

3.6 (N = 23)

   

No

Di Palma JA 1999 [22] (AM high dose)

10 days

 

5.6 (N = 50)

3.2 (N = 50)

   

No

Di Palma JA 1999 [22] (AM low dose)

10 days

 

3.8 (N = 50)

3.2 (N = 50)

   

No

Di Palma JA 1999 [22] (LT high dose)

10 days

 

4.9 (N = 17)

4.1 (N = 17)

   

No

Di Palma JA 1999 [22] (LT low dose)

10 days

 

3.2 (N = 17)

4.1 (N = 17)

   

No

Di Palma JA 2000 [23]

14 days

 

4.5 (N = 80)

2.7 (N = 71)

   

No

Di Palma JA 2007A [24]

14 days

 

8.9 (N = 46)

5.6 (N = 46)

   

Yes

Di Palma JA 2007B [25]

14 days

 

7.9 (N = 202)

5.6 (N = 100)

   

No

Klauser AG 1995 [28]

6 weeks

 

11.0 (N = 8)

3.0 (N = 8)

   

No

Andorsky RI 1990 [12] (High dose)

14 days

13.4 (N = 16)

 

7.5 (N = 16)

   

No

Andorsky RI 1990 [12] (Low dose)

14 days

8.1 (N = 16)

 

6.1 (N = 16)

   

No

Chapman RW 2013 [16]

4 weeks

4.4 (N = 68)

 

3.1 (N = 71)

   

Yes

Corazziari E 1996 [20]

4 weeks

4.8 (N = 25)

 

2.8 (N = 23)

   

No

Freedman MD 1997 [27]

14 days

6.9 (N = 57)

 

6.5 (N = 57)

5.8 (N = 57)

  

No

Zangaglia R 2007 [31]

8 weeks

6.6 (N = 29)

 

3.7 (N = 28)

   

No

Chaussade S 2003 [17] (High dose)

2 weeks

6.6 (N = 69)

8.2 (N = 67)

    

No

Chaussade S 2003 [17] (Low dose)

2 weeks

6.9 (N = 65)

6.0 (N = 65)

    

No

Seinela L 2009 [29]

2 weeks

8.7 (N = 32)

9.5 (N = 30)

    

No

Bouhnik Y 2004 [15]

28 days

 

8.8 (N = 32)

 

7.8 (N = 33)

  

No

Di Palma JA 2007C [26]

28 days

 

10.4 (N = 118)

  

8.5 (N = 116)

 

No

Attar A 1999 [13]

4 weeks

9.1 (N = 60)

  

6.3 (N = 55)

  

No

Cinca R 2013 [18]

2 weeks

3.2 (N = 120)

   

2.2 (N = 116)

 

Yes

Wang H 2005 [30]

2 weeks

8.5 (N = 63)

    

5.7 (N = 63)

No

  1. aAssessment time was 14 days after treatment initiated (if available) or at end of treatment
  2. AM Ambulatory healthy outpatients, LT Long term